No Data
Dnake (300884.SZ): The core positioning of the company's Asia Vets Logistics robot products is to provide efficient Medical supply delivery services for various indoor scenarios in Hospitals.
On December 20, Glonghui reported that Dnake (300884.SZ) stated on the investor interaction platform that the current core positioning of its Asia Vets Logistics robot products being introduced to the market is to provide efficient Medical supply delivery services for various indoor scenarios in Hospitals. The main application scenarios include laboratories, central pharmacies, inpatient departments, and operating rooms. In the future, the company will also actively explore adapting to more Logistics delivery scenarios such as Community, hotels, and parks to meet broader market demands.
Dnake (300884.SZ): The company's medical intercom system has been implemented in several retirement homes across the country.
On December 20, Glance Research reported that Dnake (300884.SZ) stated on the investor interaction platform that the company always closely follows national policy guidance and industry development trends. Based on the existing mature medical intercom system, it integrates Asia Vets functionalities and needs, and gradually extends the smart medical product line to retirement homes and at-home retirement services to meet the growing demand in the retirement market. The company's medical intercom system has already been implemented in multiple retirement homes across the country. In the future, the company hopes to further integrate Asia Vets technology and services, expanding its product line and service scope to a broader retirement field, creating new opportunities for the company.
Dnake (300884.SZ) has appointed Wang Yueshan as the financial director.
Dnake (300884.SZ) announced that the company's Board of Directors agreed to appoint Wang Yuexian as the company's Chief Financial Officer and appoint Hu Chuan...
dnake (300884.SZ): Has cumulatively repurchased 1.86% of its shares.
Dec 3rd - Dnake (300884.SZ) announced that, as of November 30, 2024, the company has repurchased 4,729,040 shares of the company through a special securities account for share buyback using the centralized competitive trading method, accounting for 1.8628% of the total share capital. The highest fill price was 10.30 yuan/share, the lowest fill price was 7.39 yuan/share, and the total amount of funds used was RMB 43.1753 million (excluding trading fees).
dnake (300884.SZ): The company is not currently involved in the field of IP economy.
Gelonghui on November 28th, dnake (300884.SZ) stated on the investor interaction platform that the company focuses on the smart community and smart hospital fields, with building intercom, smart home, and medical care intercom products as the core, also covering products related to smart community applications such as fresh air systems, intelligent passage, and smart door locks. Currently, the company is not involved in the field of IP economy.
We Think That There Are More Issues For Dnake (Xiamen) Intelligent Technology (SZSE:300884) Than Just Sluggish Earnings
Returns On Capital At Dnake (Xiamen) Intelligent Technology (SZSE:300884) Paint A Concerning Picture
No Data
